Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 48 full-time employees. The firm designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The firm`s product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.
Website: sensushealthcare.com



Growth: Bad revenue growth rate -22.2%, there is slowdown compared to average historical growth rates 12.4%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -17.1%. On average the margin is decreasing unsteadily. Gross margin is normal, +39.4%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 7.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 172.2% higher than minimum and 43.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 0.8x by EV / Sales multiple , the company can be 53.8% overvalued

Insiders: For the last 3 months insiders bought company shares on $0.1 mln (0.224% of cap.)

Key Financials (Download financials)

Ticker: SRTS
Share price, USD:  (0.0%)5.09
year average price 4.29  


year start price 5.84 2025-02-09

max close price 6.07 2025-02-10

min close price 3.09 2025-09-17

current price 5.09 2026-02-08
Common stocks: 16 320 036

Dividend Yield:  0.0%
EV / Sales: 1.7x
Margin (EBITDA LTM / Revenue): -17.1%
Fundamental value created in LTM:
Market Cap ($m): 83
Net Debt ($m): -24
EV (Enterprise Value): 59
Price to Book: 1.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-11-06seekingalpha.com

Sensus Healthcare, Inc. (SRTS) Q3 2025 Earnings Call Transcript

2025-10-16zacks.com

Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know

2025-10-08zacks.com

Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade

2025-09-29zacks.com

Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing

2025-09-22zacks.com

Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know

2025-09-10globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

2025-09-08prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

2025-08-31globenewswire.com

SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

2025-08-28globenewswire.com

Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

2025-08-25globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-12 2025-08-12 2024-11-14 2024-08-13 2024-05-10 2023-11-13 2023-08-11 2023-05-12 2022-11-10
acceptedDate 2025-11-12 14:56:42 2025-08-12 14:05:54 2025-03-05 15:56:17 2024-11-14 13:43:33 2024-08-13 14:59:09 2024-05-10 12:23:29 2024-03-15 16:41:16 2023-11-13 17:22:22 2023-08-11 12:56:47 2023-05-12 15:29:37 2023-03-23 14:09:52 2022-11-10 14:22:42 2022-03-25 16:03:27 2021-03-05 12:58:18
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 7M 7M 42M 9M 9M 11M 24M 4M 5M 3M 45M 9M 27M 10M
costOfRevenue 4M 4M 17M 4M 4M 4M 10M 2M 2M 2M 15M 3M 10M 4M
grossProfit 3M 3M 24M 5M 5M 7M 14M 2M 3M 2M 30M 6M 17M 5M
grossProfitRatio 0.394 0.397 0.593 0.587 0.625 0.51 0.579 0.475 0.652
researchAndDevelopmentExpenses 2M 1M 4M 863 000 866 000 926 000 4M 1M 822 000 1M 3M 746 000 3M 4M
generalAndAdministrativeExpenses 2M 2M 7M 2M 2M 2M 5M 2M 1M 1M 5M 1M 5M 4M
sellingAndMarketingExpenses 2M 1M 5M 1M 996 000 1M 6M 1M 2M 2M 6M 2M 5M 5M
sellingGeneralAndAdministrativeExpenses 3M 3M 12M 3M 3M 3M 11M 3M 3M 3M 11M 3M 9M 9M
otherExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
operatingExpenses 5M 5M 16M 4M 3M 4M 14M 4M 4M 5M 15M 4M 13M 13M
costAndExpenses 9M 9M 34M 7M 7M 8M 25M 6M 6M 6M 30M 7M 23M 18M
interestIncome 367 000 183 000 932 000 279 000 209 000 214 000 992 000 277 000 245 000 243 000 382 000 119 000 2000 66 000
interestExpense 0 0 0 0 0 0 0 0 0 -243 000 2000 1000 1000 14 000
depreciationAndAmortization 99 000 158 000 432 000 0 79 000 118 000 461 000 277 000 83 000 73 000 509 000 119 000 613 000 722 000
ebitda 621 999 -2M 9M 1M 2M 3M 79 000 -2M -1M -3M 15M 2M 5M -6M
ebitdaratio 0.09 -0.244 0.169 0.215 0.282 -0.415 -0.249 -0.861 0.253
operatingIncome -3M -2M 8M 1M 2M 3M -382 000 -2M -1M -3M 15M 2M 4M -8M
operatingIncomeRatio -0.373 -0.266 0.169 0.215 0.271 -0.486 -0.249 -0.861 0.24
totalOtherIncomeExpensesNet 3M 183 000 932 000 279 000 209 000 214 000 1M 42 000 245 000 243 000 13M 118 000 -1000 1M
incomeBeforeTax 522 999 -2M 9M 2M 2M 3M 652 000 -2M -882 000 -3M 28M 2M 4M -7M
incomeBeforeTaxRatio 0.076 -0.241 0.201 0.237 0.291 -0.404 -0.195 -0.79 0.253
incomeTaxExpense 1M -723 000 2M 559 000 579 000 827 000 167 000 -125 000 -502 000 -802 000 4M 450 000 0 0
netIncome -943 000 -1M 7M 1M 2M 2M 485 000 -1M -380 000 -2M 24M 2M 4M -7M
netIncomeRatio -0.137 -0.142 0.137 0.174 0.213 -0.372 -0.084 -0.555 0.203
eps -0.058 -0.064 0.41 0.074 0.099 0.14 0.03 -0.089 -0.023 -0.12 1.47 0.11 0.25 -0.42
epsdiluted -0.057 -0.064 0.074 0.099 0.14 -0.089 -0.023 -0.12 0.11
weightedAverageShsOut 16M 16M 16M 16M 16M 16M 16M 16M 16M 16M 16M 16M 16M 16M
weightedAverageShsOutDil 16M 16M 16M 16M 16M 16M 16M 16M 16M 16M 17M 17M 17M 16M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-03-15 2023-03-23 2022-03-25 2021-03-05
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 932 000 992 000 380 000 1000 52 000
ebit 8M -382 000 15M 4M -7M
nonOperatingIncomeExcludingInterest 0 0 0 -1000 -1M
netIncomeFromContinuingOperations 7M 485 000 24M 4M -7M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 7M 485 000 24M 4M -7M
epsDiluted 0.41 0.03 1.46 0.25 -0.42

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-12 2025-08-12 2024-11-14 2024-08-13 2024-05-10 2023-11-13 2023-08-11 2023-05-12 2022-11-10
acceptedDate 2025-11-12 14:56:42 2025-08-12 14:05:54 2025-03-05 15:56:17 2024-11-14 13:43:33 2024-08-13 14:59:09 2024-05-10 12:23:29 2024-03-15 16:41:16 2023-11-13 17:22:22 2023-08-11 12:56:47 2023-05-12 15:29:37 2023-03-23 14:09:52 2022-11-10 14:22:42 2022-03-25 16:03:27 2021-03-05 12:58:18
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 24M 22M 22M 23M 19M 15M 23M 20M 20M 19M 26M 38M 15M 15M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 24M 22M 22M 23M 19M 15M 23M 20M 20M 19M 26M 38M 15M 15M
netReceivables 9M 13M 20M 17M 18M 20M 11M 7M 9M 13M 17M 7M 12M 4M
inventory 14M 12M 10M 12M 13M 18M 12M 13M 10M 6M 4M 2M 2M 4M
otherCurrentAssets 2M 5M 2M 3M 4M 1M 888 000 1M 8M 11M 660 000 4M 268 000 0
totalCurrentAssets 50M 52M 57M 55M 54M 54M 50M 46M 47M 49M 53M 52M 31M 25M
propertyPlantEquipmentNet 3M 3M 3M 2M 1M 1M 1M 1M 1M 1M 1M 2M 774 000 2M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 1000 1000 25 000 50 000 74 000 146 000 338 000
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 1000 1000 25 000 50 000 74 000 146 000 338 000
longTermInvestments 0 0 0 0 0 0 0 24 000 24 000 0 0 0 0 0
taxAssets 0 3M 2M 2M 2M 1M 2M 3M 3M 3M 2M 2M 0 0
otherNonCurrentAssets 5M 535 000 652 000 590 000 654 999 688 000 804 000 281 000 350 000 443 000 492 000 36 000 75 000 69 000
totalNonCurrentAssets 8M 7M 5M 5M 4M 3M 4M 5M 5M 4M 3M 3M 995 000 3M
otherAssets 0 0 0 0 1 0 0 0 0 0 0 0 0 0
totalAssets 58M 59M 62M 60M 58M 57M 54M 51M 52M 53M 57M 55M 32M 28M
accountPayables 6M 5M 5M 4M 3M 4M 3M 4M 4M 5M 6M 5M 4M 0
shortTermDebt 257 000 252 000 0 200 000 390 000 191 000 0 183 000 181 000 192 000 0 220 000 51 000 0
taxPayables 0 0 0 0 0 37 000 37 000 0 0 0 890 000 233 000 0 0
deferredRevenue 0 529 000 541 000 686 000 686 000 948 000 657 000 708 000 692 000 671 000 693 000 1M 1M 1M
otherCurrentLiabilities 927 000 267 000 329 000 351 000 322 000 631 000 538 000 341 000 379 000 375 000 403 000 535 000 508 000 3M
totalCurrentLiabilities 7M 6M 6M 5M 5M 5M 4M 5M 5M 6M 8M 7M 6M 5M
longTermDebt 277 000 343 000 0 451 000 503 000 553 000 0 648 000 698 000 782 000 0 846 000 0 267 000
deferredRevenueNonCurrent 0 32 000 55 000 0 77 000 40 000 60 000 80 000 116 000 126 000 139 000 139 000 262 000 579 000
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 -80 000 0 0 0 0 0 0
otherNonCurrentLiabilities 21 000 0 0 66 000 0 0 0 80 000 0 0 0 -5M 0 0
totalNonCurrentLiabilities 298 000 375 000 453 000 517 000 580 000 593 000 656 000 728 000 814 000 908 000 969 000 985 000 262 000 2M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 534 000 595 000 602 000 651 000 698 000 553 000 783 000 831 000 879 000 974 000 1M 1M 174 000 1M
totalLiabilities 7M 7M 6M 6M 5M 6M 5M 6M 6M 7M 9M 8M 6M 7M
preferredStock 0 0 0 0 0 0 0 1 0 0 0 0 0 0
commonStock 169 000 169 000 169 000 169 000 169 000 169 000 169 000 169 000 169 000 169 000 169 000 169 000 167 000 166 000
retainedEarnings 9M 10M 13M 12M 11M 9M 7M 3M 4M 4M 6M 3M -18M -22M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0 0 0 0 0 0 0 0
othertotalStockholdersEquity 42M 42M 42M 42M 42M 42M 42M 42M 43M
totalStockholdersEquity 51M 52M 56M 54M 53M 51M 49M 45M 46M 46M 48M 47M 26M 21M
totalEquity 51M 52M 56M 54M 53M 51M 49M 45M 46M 46M 48M 47M 26M 21M
totalLiabilitiesAndStockholdersEquity 58M 59M 60M 58M 57M 51M 52M 53M 55M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 58M 59M 62M 60M 58M 57M 54M 51M 52M 53M 57M 55M 32M 28M
totalInvestments 0 0 0 0 0 0 0 24 000 24 000 0 0 0 0 0
totalDebt 534 000 595 000 602 000 651 000 698 000 744 000 783 000 831 000 879 000 974 000 1M 1M 225 000 1M
netDebt -24M -22M -21M -22M -18M -14M -22M -20M -19M -18M -25M -37M -14M -14M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-03-15 2023-03-23 2022-03-25 2021-03-05
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 20M 11M 17M 12M 4M
otherReceivables 0 0 0 0 0
prepaids 3M 3M 6M 3M 2M
totalPayables 5M 3M 6M 4M 0
otherPayables 0 37 000 890 000 0 0
accruedExpenses 0 0 0 0 0
capitalLeaseObligationsCurrent 204 000 187 000 190 000 174 000 303 000
capitalLeaseObligationsNonCurrent 398 000 596 000 830 000 0 812 000
treasuryStock -4M -4M -3M -325 000 -310 000
additionalPaidInCapital 46M 45M 45M 44M 44M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS SRTS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-12 2025-08-12 2024-11-14 2024-08-13 2024-05-10 2023-11-13 2023-08-11 2023-05-12 2022-11-10
acceptedDate 2025-11-12 14:56:42 2025-08-12 14:05:54 2025-03-05 15:56:17 2024-11-14 13:43:33 2024-08-13 14:59:09 2024-05-10 12:23:29 2024-03-15 16:41:16 2023-11-13 17:22:22 2023-08-11 12:56:47 2023-05-12 15:29:37 2023-03-23 14:09:52 2022-11-10 14:22:42 2022-03-25 16:03:27 2021-03-05 12:58:18
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 0 -1M 7M 1M 2M 2M 485 000 -1M -380 000 -2M 24M 2M 4M -7M
depreciationAndAmortization 98 000 158 000 432 000 102 000 78 000 118 000 461 000 199 000 83 000 73 000 509 000 75 000 613 000 721 865
deferredIncomeTax 0 -723 000 -57 000 -553 000 -331 000 827 000 -427 000 -125 000 -501 000 -802 000 -2M 2M 0 0
stockBasedCompensation 0 67 000 323 000 45 000 65 000 91 000 328 000 67 000 66 000 143 000 187 000 40 000 415 000 0
changeInWorkingCapital 0 5M -9M 3M 3M -12M -4M 2M 1M -4M -13M -551 000 -6M 6M
accountsReceivables 0 5M -9M 1M 1M -9M 7M 2M 4M 5M -5M 3M -8M 10M
inventory 0 -3M 268 000 162 000 2M -3M -9M -3M -4M -3M -3M -709 000 3M -1M
accountsPayables 0 -270 000 2M 689 000 -419 000 910 000 -3M 58 000 -987 000 -593 000 799 000 167 000 962 000 -2M
otherWorkingCapital 0 2M -2M 1M 13 000 -712 000 1M 3M 3M -5M -5M -3M -1M -955 499
otherNonCashItems -98 000 93 000 378 000 -24 000 78 000 11M 568 000 2000 118 000 163 000 -12M 188 000 705 000 118 207
netCashProvidedByOperatingActivities 0 3M -831 000 4M 4M -8M -2M 442 000 742 000 -6M -1M 4M -286 000 -434 180
investmentsInPropertyPlantAndEquipment 0 -27 000 -276 000 236 000 -3000 -233 000 -229 000 -11 000 -29 000 -189 000 -159 000 -60 000 -128 000 -358 545
acquisitionsNet 0 0 0 0 0 0 0 42 000 0 0 15M 0 257 000 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 7M
otherInvestingActivites 0 0 -573 000 0 -233 000 42 000 0 0 0
netCashUsedForInvestingActivites 0 -27 000 -337 000 -3000 -233 000 31 000 -29 000 -189 000 -60 000
debtRepayment 0 0 0 0 0 0 0 0 0
commonStockIssued 0 0 -17 000 17 000 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0 -27 000 -27 000 0 0 -3M 0 -15 000 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 -30 000 17 000 0 -12 000 0 6000 211 000
netCashUsedProvidedByFinancingActivities 0 0 -30 000 17 000 0 -39 000 0 6000 211 000
effectOfForexChangesOnCash 2M 0 0 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash 2M 3M -1M 4M 4M -8M -2M 434 000 713 000 -6M 11M 4M -388 000 7M
cashAtEndOfPeriod 24M 22M 22M 23M 19M 15M 23M 20M 20M 19M 26M 38M 15M 15M
cashAtBeginningOfPeriod 22M 19M 23M 19M 15M 23M 26M 20M 19M 26M 15M 34M 15M 8M
operatingCashFlow 0 3M -831 000 4M 4M -8M -2M 442 000 742 000 -6M -1M 4M -286 000 -434 180
capitalExpenditure 0 -27 000 -276 000 -337 000 -3000 -233 000 -229 000 -11 000 -29 000 -189 000 -159 000 -60 000 -128 000 -358 540
freeCashFlow 0 3M -1M 4M 4M -8M -2M 431 000 713 000 -6M -2M 4M -414 000 -792 720
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-03-15 2023-03-23 2022-03-25 2021-03-05
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 42 000 0 0 0
netCashProvidedByInvestingActivities -276 000 -187 000 15M 129 000 7M
netDebtIssuance 0 0 -51 000 -216 000 266 777
longTermNetDebtIssuance 0 0 -51 000 -216 000 266 777
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 67 000 -27 000 -3M -15 000 560
netCommonStockIssuance 67 000 -27 000 -3M -15 000 560
commonStockIssuance 67 000 0 0 0 560
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -52 000 -13 000 622 000 0 -57 331
netCashProvidedByFinancingActivities 15 000 -40 000 -2M -231 000 210 006
incomeTaxesPaid 3M 1M 5M 0 0
interestPaid 0 0 2000 0 0

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-08-08 ET (fiscal 2025 q2)
2025 q1
2025-05-15 ET (fiscal 2025 q1)
2024 q4
2025-02-05 ET (fiscal 2024 q4)
2024 q3
2024-11-14 ET (fiscal 2024 q3)
2024 q2
2024-08-11 ET (fiscal 2024 q2)
2024 q1
2024-05-11 ET (fiscal 2024 q1)
2023 q4
2024-02-08 ET (fiscal 2023 q4)
2023 q3
2023-11-09 ET (fiscal 2023 q3)
2023 q2
2023-08-06 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-09 ET (fiscal 2022 q4)
2022 q3
2022-11-06 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-08 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-06 16:15 ET
Sensus Healthcare reported for 2025 q3
SEC form 8
2025-11-06 16:15 ET
Sensus Healthcare published news for 2025 q3
SEC form 10
2025-08-12 18:05 ET
Sensus Healthcare reported for 2025 q2
SEC form 8
2025-08-07 20:12 ET
Sensus Healthcare published news for 2025 q2
SEC form 8
2025-08-07 20:12 ET
Sensus Healthcare published news for 2025 q2
SEC form 10
2025-05-15 20:14 ET
Sensus Healthcare reported for 2025 q1
SEC form 8
2025-05-15 20:12 ET
Sensus Healthcare published news for 2025 q1
SEC form 8
2025-05-15 20:12 ET
Sensus Healthcare published news for 2025 q1
SEC form 10
2025-05-15 00:00 ET
Sensus Healthcare published news for 2025 q1
SEC form 10
2025-03-05 20:56 ET
Sensus Healthcare published news for 2024 q4
SEC form 10
2025-03-05 00:00 ET
Sensus Healthcare published news for 2024 q4
SEC form 8
2025-02-05 00:00 ET
Sensus Healthcare published news for 2024 q4
SEC form 8
2025-02-05 00:00 ET
Sensus Healthcare reported for 2024 q4
SEC form 8
2024-11-18 12:47 ET
Sensus Healthcare published news for 2024 q3
SEC form 8
2024-11-18 12:47 ET
Sensus Healthcare published news for 2024 q3
SEC form 10
2024-11-14 13:43 ET
Sensus Healthcare reported for 2024 q3
SEC form 10
2024-11-14 00:00 ET
Sensus Healthcare published news for 2024 q3
SEC form 8
2024-11-14 00:00 ET
Sensus Healthcare published news for 2024 q3
SEC form 8
2024-11-14 00:00 ET
Sensus Healthcare published news for 2024 q3
SEC form 10
2024-08-13 00:00 ET
Sensus Healthcare reported for 2024 q2
SEC form 8
2024-08-08 16:10 ET
Sensus Healthcare published news for 2024 q2
SEC form 8
2024-08-08 16:10 ET
Sensus Healthcare published news for 2024 q2
SEC form 10
2024-05-10 00:00 ET
Sensus Healthcare reported for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Sensus Healthcare published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Sensus Healthcare published news for 2024 q1
SEC form 10
2024-03-15 16:41 ET
Sensus Healthcare published news for 2023 q4
SEC form 10
2024-03-15 00:00 ET
Sensus Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Sensus Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Sensus Healthcare reported for 2023 q4
SEC form 10
2023-11-13 00:00 ET
Sensus Healthcare published news for 2023 q3
SEC form 8
2023-11-09 16:07 ET
Sensus Healthcare reported for 2023 q3
SEC form 10
2023-08-11 00:00 ET
Sensus Healthcare published news for 2023 q2
SEC form 6
2023-08-03 16:05 ET
Sensus Healthcare reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Sensus Healthcare published news for 2023 q2
SEC form 6
2023-06-06 16:01 ET
Sensus Healthcare published news for 2023 q1
SEC form 10
2023-05-12 00:00 ET
Sensus Healthcare published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Sensus Healthcare published news for 2023 q1
SEC form 10
2023-03-23 14:09 ET
Sensus Healthcare reported for 2022 q4
SEC form 10
2023-03-23 00:00 ET
Sensus Healthcare reported for 2022 q4
SEC form 6
2023-02-09 16:00 ET
Sensus Healthcare published news for 2022 q4
SEC form 8
2023-02-09 00:00 ET
Sensus Healthcare reported for 2022 q4
SEC form 6
2023-01-09 17:00 ET
Sensus Healthcare published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Sensus Healthcare published news for 2022 q4
SEC form 10
2022-11-10 14:22 ET
Sensus Healthcare reported for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Sensus Healthcare reported for 2022 q3
SEC form 6
2022-11-03 16:13 ET
Sensus Healthcare published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Sensus Healthcare reported for 2022 q3
SEC form 10
2022-08-12 13:03 ET
Sensus Healthcare reported for 2022 q2
SEC form 10
2022-08-12 00:00 ET
Sensus Healthcare reported for 2022 q2
SEC form 6
2022-08-04 16:12 ET
Sensus Healthcare published news for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Sensus Healthcare reported for 2022 q2
SEC form 6
2022-06-09 09:00 ET
Sensus Healthcare published news for 2022 q1
SEC form 10
2022-05-12 16:23 ET
Sensus Healthcare reported for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Sensus Healthcare reported for 2022 q1
SEC form 6
2022-05-05 16:12 ET
Sensus Healthcare published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Sensus Healthcare reported for 2022 q1
SEC form 6
2022-04-29 09:54 ET
Sensus Healthcare published news for 2022 q1
SEC form 10
2022-03-25 16:03 ET
Sensus Healthcare published news for 2021 q4
SEC form 10
2022-03-25 00:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-03-09 11:33 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-03-03 13:35 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-02-10 16:45 ET
Sensus Healthcare published news for 2021 q4
SEC form 8
2022-02-10 00:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-01-31 16:10 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-01-05 14:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 8
2022-01-05 00:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 10
2021-11-10 14:23 ET
Sensus Healthcare published news for 2021 q3
SEC form 10
2021-11-10 00:00 ET
Sensus Healthcare published news for 2021 q3
SEC form 6
2021-11-04 16:18 ET
Sensus Healthcare published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Sensus Healthcare published news for 2021 q3
SEC form 10
2021-08-13 10:09 ET
Sensus Healthcare published news for 2021 q2
SEC form 10
2021-08-13 00:00 ET
Sensus Healthcare published news for 2021 q2
SEC form 6
2021-08-05 16:17 ET
Sensus Healthcare published news for 2021 q2
SEC form 6
2021-06-04 16:00 ET
Sensus Healthcare published news for 2021 q1
SEC form 10
2021-05-14 12:19 ET
Sensus Healthcare published news for 2021 q1
SEC form 10
2021-05-14 00:00 ET
Sensus Healthcare published news for 2021 q1
SEC form 6
2021-05-06 16:05 ET
Sensus Healthcare published news for 2021 q1
SEC form 6
2021-04-30 12:42 ET
Sensus Healthcare published news for 2021 q1
SEC form 10
2021-03-05 12:58 ET
Sensus Healthcare published news for 2020 q4
SEC form 6
2021-02-25 16:11 ET
Sensus Healthcare published news for 2020 q4
SEC form 6
2021-01-11 11:02 ET
Sensus Healthcare published news for 2020 q4
SEC form 10
2020-11-10 13:44 ET
Sensus Healthcare published news for 2020 q3
SEC form 6
2020-11-05 17:09 ET
Sensus Healthcare published news for 2020 q3
SEC form 6
2020-11-05 16:14 ET
Sensus Healthcare published news for 2020 q3
SEC form 6
2020-10-01 17:32 ET
Sensus Healthcare published news for 2020 q3